Zobrazeno 1 - 10
of 41
pro vyhledávání: '"J. Matthew Hutzler"'
Autor:
Taysir Chamem, Xiaochun Zhu, Todd Hieronymus, Richard D. Burton, J. Matthew Hutzler, Shelby Anderson, David Heim
Publikováno v:
Drug Metabolism and Disposition. 46:1617-1625
Metabolic profiles of four drugs possessing diverse metabolic pathways (timolol, meloxicam, linezolid, and XK469) were compared following incubations in both suspended cryopreserved human hepatocytes and the HμREL hepatocyte coculture model. In gene
Autor:
John D. Huber, J. Matthew Hutzler, Doris Riether, Tom Simpson, Alan Olague, Asitha Abeywardane, Renee Zindell, John Broadwater, Peter Allen Nemoto, Hidenori Takahashi, Todd Bosanac, Yunlong Zhang, Alessandra Bartolozzi, Zhidong Chen, Lifen Wu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:4652-4659
Structure activity relationship (SAR) investigation of an oxadiazole based series led to the discovery of several potent FLAP inhibitors. Lead optimization focused on achieving functional activity while improving physiochemical properties and reducin
Publikováno v:
Xenobiotica. 48:219-231
1. Failure to predict human pharmacokinetics of aldehyde oxidase (AO) substrates using traditional allometry has been attributed to species differences in AO metabolism. 2. To identify appropriate species for predicting human in vivo clearance by sin
Publikováno v:
The AAPS Journal. 18:1391-1405
Over the years, significant progress has been made in reducing metabolic instability due to cytochrome P450-mediated oxidation. High-throughput metabolic stability screening has enabled the advancement of compounds with little to no oxidative metabol
Autor:
Michael Huskin, Jennifer Wood, Nicholas Ingram, J. Matthew Hutzler, Sherri Smith, Christopher Dishinger
Publikováno v:
The AAPS journal. 21(1)
Fraction unbound (fu) is a critical drug distribution parameter commonly utilized for modeling efficacious dosage and safety margin predictions. An over-estimation of fu for 13 chemically diverse small molecule drugs primarily bound to alpha-1-acid g
Autor:
Richard D, Burton, Todd, Hieronymus, Taysir, Chamem, David, Heim, Shelby, Anderson, Xiaochun, Zhu, J Matthew, Hutzler
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 46(11)
Metabolic profiles of four drugs possessing diverse metabolic pathways (timolol, meloxicam, linezolid, and XK469) were compared following incubations in both suspended cryopreserved human hepatocytes and the H
Autor:
Adam Flegg, Tina Morwick, Ho Yin Lo, Todd Bosanac, Weimin Liu, Valentina Berger, Steven Kerr, Stéphane De Lombaert, Paige Erin Mahaney, Ralph Binetti, John Broadwater, Spencer Napier, Alessandra Bartolozzi, Lifen Wu, Hidenori Takahashi, Asitha Abeywardane, Heather Tye, Tazmeen Fadra-Khan, John D. Huber, Adrian Kotey, Ming-Hong Hao, Dines Jonathon Alan, Anil Kumar Padyana, Alan Olague, Michael Garrigou, David S. Thomson, J. Matthew Hutzler, Pui Leng Loke, Renee Zindell, Edward Pack, Zhidong Chen, Rebecca Crux, Thomas Simpson, Rajvee Dave, Doris Riether
Publikováno v:
Journal of Medicinal Chemistry. 58:1669-1690
The synthesis, structure–activity relationship (SAR), and evolution of a novel series of oxadiazole-containing 5-lipoxygenase-activating protein (FLAP) inhibitors are described. The use of structure-guided drug design techniques provided compounds
Autor:
Constance Asher, Diane Wong, J. Matthew Hutzler, Young-Sun Yang, Matthew A. Cerny, Kyle E. Gilpin, Kosea Frederick
Publikováno v:
Drug Metabolism and Disposition. 42:1751-1760
BIBX1382 was an epidermal growth factor receptor inhibitor under clinical investigation for treatment of cancer. This candidate possessed an attractive preclinical absorption, distribution, metabolism, and excretion profile, yet failed in clinical st
Publikováno v:
Drug Metabolism and Pharmacokinetics. 33:S68-S69
Publikováno v:
Drug Metabolism and Disposition. 40:1336-1344
The current studies assessed the utility of freshly plated hepatocytes, cryopreserved plated hepatocytes, and cryopreserved plated HepaRG cells for the estimation of inactivation parameters k(inact) and K(I) for CYP3A. This was achieved using a subse